|
?:authorAffiliation
|
-
[\'Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA.\', \'Center for Health + Technology, University of Rochester Medical Center, Rochester, New York, USA.\', \'Sage Bionetworks, Seattle, Washington, USA.\', \'Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Harvard Medical School, Boston, Massachusetts, USA.\', \'The Michael J. Fox Foundation for Parkinson\'s Research, New York, New York, USA.\', \'Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Division of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA.\', \'Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.\', \'Parkinson\'s Foundation, New York, New York, USA.\', \'Eli Lilly and Company, Indianapolis, Indiana, USA.\', \'Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USA.\', \'Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco Veterans Affairs Health Care System, San Francisco, California, USA.\', \'Department of Biostatistics, University of Rochester Medical Center, Rochester, New York, USA.\', \'Grey Matter Technologies, Sarasota, Florida, USA.\', \'Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}